Objective: Earlier studies and trials have shown a serum cholesterol raising effect of unfiltered coffee, which is reduced by about 80% in filtered coffee. Recent cross-sectional studies and trials, however, have indicated that filtered coffee may have a more pronounced serum cholesterol raising effect than previously anticipated. The objective of this controlled study was to assess the effects of the intake and abstention of filtered brewed coffee on blood lipids. Design: A prospective, controlled study with four consecutive trial periods. The first and third periods were 3 weeks of total coffee abstention. The second and fourth periods consisted of 4 weeks with the subjects consuming 600 ml filter brewed coffee/ day. Setting: Free-living population. Volunteers. Subjects: A total of 121 healthy, nonsmoking men and women aged 29-65 y. Interventions: Not applicable. Main outcome measures: Serum total cholesterol, serum HDL cholesterol, serum triglycerides, serum lipoprotein (a) (Lp(a)), blood pressure and heart rate. Results: The two coffee abstention periods were associated with a decline in serum cholesterol of 0.22 mmol/l (95% CI À0.31, À0.13) and 0.36 mmol/l (95% CI À0.46, À0.26), respectively. Filtered coffee/day 600 ml increased serum cholesterol by 0.25 mmol/l (95% CI 0.15, 0.36) and 0.15 mmol/l (95% CI 0.04, 0.26) during the two coffee drinking periods. Conclusions: Coffee abstention for 3 weeks decreased total serum cholesterol by 0.22-0.36 mmol/l. A volume of 600 ml (about four cups) of filtered coffee/day during 4 weeks raised total serum cholesterol by 0.15-0.25 mmol/l.
Introduction
Almost two decades ago it was shown that the consumption of coffee was associated with total serum cholesterol (Thelle et al, 1983) . Further studies revealed that the cholesterolraising effect was because of the natural content of the diterpenes kahweol and cafestol in the green coffee beans (Zock et al, 1990; Weusten-Van der Wouw et al, 1994; Urgert & Katan, 1997) . A number of studies showed that a major part of the diterpenes is retained by a paper filter, whereby the cholesterol-raising effect of coffee is substantially reduced (Bak, 1990; Ahola et al, 1991; Van Dusseldorp et al, 1991) . Bak (1990) showed in her meta-analysis that total cholesterol increased by an average of 0.008 mmol/l per cup of filtered coffee, compared to 0.038 mmol/l per cup of unfiltered or boiled coffee. These figures are seemingly in contrast to the findings by Fried et al (1992) and to some extent by Superko et al (1991) where filtered coffee was also associated with a larger increase in serum cholesterol than previously reported. Urgert and Katan (1997) commented on these discrepancies in their review on the cholesterol-raising effect of coffee and were inclined to ascribe these different findings to chance. In a recent study, however, we observed a decrease of 0.28 mmol/l after quitting drinking on average 4.9 cups of filtered coffee for 6 weeks (Christensen et al, 2001) . This led us to assess the effects of the intake and abstention of filtered brewed coffee on blood lipids in a controlled study, originally aiming at the effects of folate and pyridoxine supplementation on the homocysteine-raising effect of coffee (Strandhagen et al, 2002) .
Methods

Study design
The study was organised as a prospective, controlled study with four consecutive trial periods. The first and third periods were 3 weeks of total coffee abstention. The second and fourth periods consisted of 4 weeks with the subjects consuming 600 ml filter brewed coffee/day.
The main outcome or effect variable was total serum cholesterol and the effect was assessed as the difference between the measurements at the beginning and the end of the coffee-free periods (coffee abstention) and the difference between measurements at the beginning and at the end of the 4 weeks of coffee consumption, see Figure 1 . A trial duration of 3-4 weeks has previously been shown to be sufficient to get an effect of coffee on serum cholesterol (Grubben et al, 2000; Christensen et al, 2001 ).
Subjects and procedure
The participants were recruited by advertisement in the largest newspaper in Gothenburg. Inclusion criteria were age range 30-65 y, free of clinically recognised chronic diseases such as cardiovascular diseases, cancer, renal disorders, liver disease and diabetes mellitus. They were not on antiepileptic or cholesterol-lowering drugs, had been using coffee on a regular basis for at least 5 y and were currently nonsmokers (at least for the last 6 months).
During the coffee drinking periods, the participants were instructed to drink about 600 ml filter brewed coffee/day (four cups), according to standardised measures. The coffee was provided to guarantee that they were all exposed to the same brand and quality of filter brewed coffee. All participants also got the same kind of standardised coffee filter and measuring spoon.
The coffee filters used were of the brand Euro-Shopper, made by Indupa NV, Zaventem, Belgium.
After the first 3 weeks of coffee abstention, the participants were instructed to consume 600 ml coffee (four cups/day). This period was followed by another 3 weeks of coffee abstention; thereafter, the participants were again asked to take up drinking 600 ml of coffee/day for another 4 weeks.
Divergence from the four cups was reported. The participants were allowed to drink tea and other caffeine-containing beverages during the coffee-free periods.
Effect variables
Nonfasting blood samples were drawn at inclusion and at 3, 7, 10 and 14 weeks after start of the study. Prior to analysis, prepared serum was stored at À701 C.
The blood samples were analysed for blood lipids (total cholesterol, HDL cholesterol, triglycerides, lipoprotein(a) (Lp(a)) and urate in serum. Serum cholesterol and triglycerides were determined by an enzymatic procedure on a Hitachi 917 analyzer. HDL cholesterol was determined enzymatically after precipitation of VLDL, LDL and chylomicrones by a-cyclodextrinsulphate and dextransulphate. Determination of Lp(a) was done by the method Tint Elize Lp(a) of Biopool International. Serum urate was analysed by Hitachi 917 autoanalyser. Body mass index (BMI; kg/m 2 ) was recorded once during the study. Blood pressure was recorded by manual device, and EKG and heart rate were recorded at all five visits.
The dietary habits were assessed by dietary frequency questionnaires at the beginning of the study. A follow-up survey with special emphasis on changes in food habits during the four different periods was undertaken. The dietary questionnaire was based upon a Norwegian version, which has been used in a number of previous studies (Nes et al, 1992) .
Statistical methods
All analyses were performed using the SAS r software. The statistical significance of the differences was assessed by Student's t-test except for Lp(a). For this variable, signed rank test was used. P-values o0.05 were considered statistically 
Results
Coffee intake and blood lipids, blood pressure and heart rate A total of 156 people responded to the advertisement and of these 124 fulfilled the criteria and were able to take part. Three people decided to withdraw during the study, leaving a total of 121 participants. One participant was not able to take part during the first period and five people were not able to take part in the last period, which resulted in 120 participants in the first trial period and 116 in the subsequent trial period. Serum total cholesterol decreased by 0.22 mmol/l (95% CI: À0.31, À0.13) and 0.36 mmol/l (95% CI: À0.46, À0.26) during the two 3 weeks coffee abstention periods (Table 1 ).
The decreases in HDL cholesterol were only 0.02 mmol/l (95% CI À0.06, 0.02) and 0.09 mmol/l (95% CI À0.12, À0.06), respectively. Serum triglycerides showed an inconsistent pattern with a significant decline during the first coffee abstention period, but a much smaller effect during the second abstention period. Serum urate fell by 11 mmol/l (95% CI À19.7, À2.4) and 15.1 mmol/l (95% CI À20.9, À9.3) during the two abstention periods, both statistically significant. Differences in heart rate were small and insignificant. Both systolic and diastolic blood pressure fell significantly during the first abstention period but the results were insignificant for the last abstention period.
The effects of consuming 600 ml filtered coffee/day for 4 weeks are shown in Table 2 .
Total serum cholesterol increased during both trial periods by 0.25 mmol/l (95% CI 0.15, 0.36) and 0.15 mmol/l (95% CI 0.04, 0.26), respectively. There was also an incrementing effect on serum HDL cholesterol, serum triglycerides, serum urate, systolic blood pressure and heart rate in both periods, but the differences were significant only for serum urate in Table 1 Effect of 3 weeks of coffee abstention in trial period 1(weeks 0-3), n=120 and trial period 2 (weeks 7-10), n=116.
Period 1
Period 2
Diff.
95% Table 2 Effect of four cups (600 ml) of filtered coffee/day for 4 weeks in trial period 1 (weeks 3-7), n=120 and trial period 2 (weeks 10-14), n=116. the first period (12.9 mmol/l, 95% CI 5.7, 20.1) and systolic blood pressure in the second period (2.1 mmHg, 95% CI). The decline in total cholesterol during coffee abstention was significantly larger during the second trial period, whereas the cholesterol increase was larger during the first coffee exposure period. The Lp(a) values were not normally distributed, and only median values and range are presented here. There was no difference in the first coffee abstention period (median +2 mmol/l, range 256, À109) but a significant increase in the second abstention period (median +15 mmol/l, range 126, À297). Coffee consumption resulted in significant decreases of serum Lp(a) in both trial periods (median À11 mmol/l, range 180, À108 in the first trial period and median À4 mmol/l, range 338, À208 in the second trial period).
None of the above results were influenced by the folate or pyridoxine supplementation.
Dietary monitoring and compliance
Of the 121 participants, 89 (74%) reported filter brewed coffee as their usual coffee. Unfiltered coffee (boiled, percolator, French pressed) was consumed by 15 people (12%) and nine people (7%) consumed instant coffee only (Table 3 ). The average coffee intake prior to the study was 3.9 cups/day (s.d. 1.83). Mean levels of BMI and age, and gender distribution, are shown in Table 3 .
The dietary survey showed that the intake of buns and cakes was unchanged in 100 of the 120 participants in the first coffee abstention period, and in 107 of the 116 participants for the second period (Table 4) . For the coffee drinking period, the corresponding figures were 104 of 120, and 110 of 116, respectively. Intake of milk was unchanged in 97 of 120 participants and 99 of 116 for the two coffee abstention periods, and in 109 of 120 and 112 of 116 participants for the two coffee drinking periods.
Coffee consumption or noncompliance was reported by six people during the first coffee abstention period (mean 1.8 cups/period), whereas four people reported coffee consumption in the second coffee abstention period (mean 0.7 cups/ period).
Consistency in the effects
A majority of the participants showed similar changes in blood lipids. In the two coffee abstention periods, 73 of 120 and 83 of 116 participants showed a decrease in serum cholesterol. Coffee drinking resulted in increasing serum cholesterol values in 81 of 120 participants in the first period, and in 64 of 116 the participants in the second coffee period.
Discussion
The effect of abstaining from filtered coffee for 3 weeks resulted in a serum cholesterol decrease of about 0.22-0.36 mmol/l, whereas 600 ml (about 4 cups) of filtered coffee/day resulted in an increase by 0.15-0.25 mmol/l. These changes are unlikely a consequence of chance or confounding dietary factors such as changes in other food items corresponding to coffee intake. Coffee abstention may lead to either a reduction in milk consumption (coffee with milk) or an increase to compensate a decreased fluid intake. In this study, more than 80% of the participants reported no change of milk consumption in the coffee abstention periods. As a comparison, 600 ml of whole fat milk (3% fat, daily energy intake 2000 kcal) should itself result in a change in serum cholesterol by 0.34 mmol/l, according to the formula of Keys et al (1965) .
The blood lipid changes in the present study were consistent with the results of Superko et al (1991) , Fried et al (1992) and Christensen et al (2001) . In the study by Fried et al, total cholesterol increased by 0.24 mmol/l after the consumption of 7.2 dl (five cups) of filtered coffee for 8 weeks, whereas Christensen et al (2001) showed a decrease of 0.28 mmol/l after quitting drinking on average 4.9 cups of filtered coffee for 6 weeks Superko et al (1991) reported that the consumption of decaffeinated coffee resulted in an increment in serum cholesterol compared to regular coffee or no coffee at all. The differences were in both cases 0.21 mmol/l. This study differed from the other studies in design, but the results were of the same magnitude. The serum cholesterol decrease in the present study was larger in the second coffee abstention period, most likely because of a more standardised coffee exposure prior to the coffee abstention. Jee et al (2001) showed in a meta-analysis a change in serum cholesterol caused by unfiltered coffee by 0.6 mmol/l when comparing coffee drinkers with noncoffee drinkers. The use of filtered coffee resulted only in a 0.08 mmol/l change. This meta-analysis contained 18 studies including a total of 885 participants. In the 10 studies of filtered coffee, 579 people participated. Compared to that, the present study as well as that by Fried et al (1992) , Christensen et al (2001) and Superko et al (1991) included 701 participants. The 18 studies in the Metaanalysis are likely to be more heterogeneous than the three larger studies, which have shown an effect of filtered coffee.
Another possible explanation is that the quality of the paper filter differs, whereby more or less of the diterpenes pass through the filters and into the coffee. A further study of the paper quality and the physical properties of the filters is therefore warranted.
The magnitude of the serum cholesterol changes in the present study corresponds to the effect of unfiltered coffee in an earlier meta-analysis (Bak, 1990) , the review of Urgert and Katan (1997) and results from the Swedish part of the MONICA study (Strandhagen et al 2000, abstract) .
Our results with regard to Lp(a) are inconsistent in the sense that Lp(a) did not change during the first coffee abstention period but increased during the next noncoffee period. The Lp(a) levels fell, on the other hand during both the coffee periods, which corresponds to Urgert et al (1997) who showed an Lp(a)-reducing effect of diterpenes. The standard deviations of Lp(a) were very wide in the present study, indicating a large interindividual variation. Thus, the power to show true effects of low-diterpene-containing coffee on Lp(a) is likely to be small.
The public health consequences of the present findings can be assessed by the study of Pietinen et al (1996) of dietary changes in the Finnish diet during the years 1972-1992. They assumed that filter brewed coffee had a lower cholesterol increasing effect than unfiltered coffee, whereby 0.3 mmol/l of the serum cholesterol reduction of about 1 mmol/l on the Finnish population could be ascribed to changes in coffee brewing habits. Such differences correspond to 10-15% higher or lower incidence of coronary heart disease. The possibility that filter brewed coffee raises serum cholesterol levels, to the extent which is shown in this paper, is particularly of interest in the Nordic countries having the world's highest coffee consumption (kg/person/y) (International Coffee Organization, 2001 ).
Coffee consumption, therefore, should be discussed in the advising of hyperlipaemic subjects who may do well by reducing their coffee consumption.
